ArticleMikrochimica acta2026
Interfacial engineering-tailored self-cascading nanozyme for sensitive and rapid detection of different amylases.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The precise quantification of amylases activities in complex environments is crucial in actual manufacturing. We synthesized a self-cascading nanozyme (Au@MOF-235) with glucose oxidase (GOx)-mimicking and peroxidase (POD)-mimicking ability. The stable electrostatic interaction guarantees the homogeneous immobilization of Au nanoparticles with a remarkable GOx-simulating property and thorough active site exposure of MOF-235. Moreover, the generated gluconic acid modulates the acidic level and boosts the POD-mimetic behavior of MOF-235. Consequently, we constructed a platform for sensitive determination of four amylases, demonstrating wide linear ranges (α-amylase: 4-400 U/L, β-amylase: 4-500 U/L, γ-amylase: 10-300 U/L, and pullulanase: 10-400 U/L) and low detection limits (α-amylase: 1.74 U/L, β-amylase: 1.85 U/L, γ-amylase: 5.76 U/L, and pullulanase: 3.68 U/L). This study offers a reliable approach for tracking amylases during food manufacturing with advanced self-cascading and self-activating nanozymes.
Indexed as
Identifiers
42900251What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.